(Q41199801)

English

Increased Total Homocysteine Levels Predict the Risk of Incident Dementia Independent of Cerebral Small-Vessel Diseases and Vascular Risk Factors

scientific article published on 17 October 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

Increased Total Homocysteine Levels Predict the Risk of Incident Dementia Independent of Cerebral Small-Vessel Diseases and Vascular Risk Factors (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

1 reference

based on heuristic

inferred from title

7

object named as

Kazuo Kitagawa

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

author name string

Kaori Miwa

1

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

Makiko Tanaka

2

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

Shuhei Okazaki

3

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

Yoshiki Yagita

4

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

Manabu Sakaguchi

5

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

Hideki Mochizuki

6

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

publication date

17 October 2015

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

Journal of Alzheimer's Disease

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

49

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

503-513

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150458

21 January 2018

Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150458

21 January 2018

Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150458

21 January 2018

Plasma homocysteine as a risk factor for dementia and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150458

21 January 2018

Midlife homocysteine and late-life dementia in women. A prospective population study.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150458

21 January 2018

Plasma homocysteine and MTHFRC677T polymorphism as risk factors for incident dementia.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150458

21 January 2018

Homocysteine and holotranscobalamin and the risk of Alzheimer disease: a longitudinal study

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150458

21 January 2018

Plasma homocysteine levels and risk of Alzheimer disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150458

21 January 2018

Vitamin B12, folate, homocysteine and dementia: are they really related?

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150458

21 January 2018

The blood-brain barrier in health and chronic neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150458

21 January 2018

Cerebrovascular disease and mechanisms of cognitive impairment: evidence from clinicopathological studies in humans

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150458

21 January 2018

Chronic kidney disease is associated with dementia independent of cerebral small-vessel disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150458

21 January 2018

Multiple or mixed cerebral microbleeds and dementia in patients with vascular risk factors

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150458

21 January 2018

The effect of folic acid based homocysteine lowering on cardiovascular events in people with kidney disease: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150458

21 January 2018

Association between interleukin-6 levels and first-ever cerebrovascular events in patients with vascular risk factors

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150458

21 January 2018

“Mini-mental state”

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150458

21 January 2018

A new clinical scale for the staging of dementia.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150458

21 January 2018

Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150458

21 January 2018

A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150458

21 January 2018

Different MRI findings for normal elderly and very mild Alzheimer's disease in a community: implications for clinical practice the Tajiri Project.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150458

21 January 2018

Measuring cerebral atrophy and white matter hyperintensity burden to predict the rate of cognitive decline in Alzheimer disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150458

21 January 2018

International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150458

21 January 2018

Diagnostic criteria for dyslipidemia. Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150458

21 January 2018

Revised equations for estimated GFR from serum creatinine in Japan

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150458

21 January 2018

Associations of serum IL-18 levels with carotid intima-media thickness

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150458

21 January 2018

Serum inflammatory proteins and frontal lobe dysfunction in patients with cardiovascular risk factors

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150458

21 January 2018

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150458

21 January 2018

Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150458

21 January 2018

Vascular subcortical hyperintensities predict conversion to vascular and mixed dementia in MCI patients.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150458

21 January 2018

Homocysteine induces programmed cell death in human vascular endothelial cells through activation of the unfolded protein response

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150458

21 January 2018

Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150458

21 January 2018

B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150458

21 January 2018

Homocysteine and progression of generalized small-vessel disease: the SMART-MR Study

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150458

21 January 2018

Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150458

21 January 2018

Plasma homocysteine, Alzheimer and cerebrovascular pathology: a population-based autopsy study

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150458

21 January 2018

Association of plasma total homocysteine levels with subclinical brain injury: cerebral volumes, white matter hyperintensity, and silent brain infarcts at volumetric magnetic resonance imaging in the Framingham Offspring Study

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150458

21 January 2018

Homocysteine exacerbates β-amyloid pathology, tau pathology, and cognitive deficit in a mouse model of Alzheimer disease with plaques and tangles

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150458

21 January 2018

Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150458

21 January 2018

Effects of homocysteine lowering with B vitamins on cognitive aging: meta-analysis of 11 trials with cognitive data on 22,000 individuals

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150458

21 January 2018

Homocysteine and brain atrophy on MRI of non-demented elderly

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150458

21 January 2018

Identifiers

10.3233/JAD-150458

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41199801&oldid=2094226335"